Does a positive Epstein-Barr Virus (EBV) Viral Capsid Antigen Immunoglobulin G (IgG) disqualify someone from being a living kidney donor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Positive EBV Viral Capsid Antigen IgG and Living Kidney Donation

A positive Epstein-Barr Virus (EBV) Viral Capsid Antigen IgG does not disqualify someone from being a living kidney donor, as EBV seropositivity is extremely common in the adult population and is part of standard infectious disease screening for all potential donors. 1, 2

Standard Infectious Disease Screening for Living Kidney Donors

  • All potential living kidney donors must undergo comprehensive infectious disease screening, including testing for EBV, CMV, HIV, HBV, HCV, and syphilis 1, 3
  • EBV testing is specifically included in the standard screening panel recommended by the American Journal of Kidney Diseases 2
  • Testing should be performed or updated within 28 days of donation to ensure accuracy 1

Interpretation of Positive EBV VCA IgG Results

  • A positive EBV VCA IgG indicates past infection and immunity, which is extremely common in the adult population 4
  • In some regions like Iran, studies have shown 100% EBV seroprevalence among potential kidney donors and recipients over age 18 4
  • EBV seropositivity alone is not a contraindication to donation and is actually preferable in many cases 5

EBV Serostatus Matching Considerations

  • The donor-recipient EBV serostatus match is more important than the donor's serostatus alone 5
  • High-risk EBV mismatches occur when an EBV-positive donor donates to an EBV-negative recipient, which can lead to primary infection in the immunosuppressed recipient 5, 6
  • A positive EBV VCA IgG in both donor and recipient (D+/R+) is considered a low-risk combination 6
  • Only the rare D+/R- combination (positive donor to negative recipient) presents higher risk for primary EBV infection post-transplant 6

Risk Assessment Framework

  • If a donor candidate is found to have any potentially transmissible infection, the transplant team should weigh the risks and benefits of proceeding with donation 1
  • For EBV specifically, the presence of IgG antibodies alone represents past infection rather than active infection and does not typically prevent donation 2
  • The transplant team must evaluate the complete infectious disease profile of both donor and recipient to make appropriate decisions 3

Common Pitfalls to Avoid

  • Failing to distinguish between past infection (IgG positive) and active infection (IgM positive) can lead to unnecessary exclusion of potential donors 6
  • Not considering the recipient's EBV serostatus when evaluating donor candidacy may miss opportunities to prevent high-risk mismatches 5
  • Overlooking the importance of testing timing (within 28 days of donation) can lead to inaccurate risk assessment 1

In conclusion, a positive EBV VCA IgG result indicates past infection and immunity, which is extremely common in adults and does not disqualify someone from being a living kidney donor. The donor-recipient EBV serostatus match is more important than the donor's status alone, with D+/R+ combinations being low-risk for complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Comprehensive Testing for Potential Living Kidney Donors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Infectious Disease Screening for Living Kidney Donors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epstein-Barr virus infection after kidney transplantation.

Transplant international : official journal of the European Society for Organ Transplantation, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.